Professional Study Out of Israel Shows Disturbing Number of Serious Side Effects From C0VID Vaxxines
Israeli Booster Safety Data published in Hebrew on February 10 shows disturbing trend of serious side effects from majority of booster recipients.
Back in August 2021 Israeli health authorities published preliminary booster safety data showing that a full one percent of people, i.e. one in one hundred, had to “seek medical help” due to booster side effects. But two weeks ago, the Israeli Ministry of Health (MoH) published a new report that provides much more detailed, and much more disturbing, data on covid vaccine booster side effects.
The original MoH report, published in Hebrew on February 10, 2022, was translated into English on February 15 by US-Israeli retired medical professor Eyal Shahar and several volunteers.
The Israeli Reporting system utilises active tracking to collect and collate results, in contrast to passive reporting systems like the US VAERS system which typically cover only a fraction of actual side effects. The Israeli report is based on an active survey that directly asked booster recipients about any side effects they may have experienced rather than waiting for recipients to ‘self-report’ side effects.
Specifically, the report is based on a professional telephone survey, conducted between 19 September and 25 October 2021, that covered a representative, random sample of 2049 people, stratified by age group and gender, out of about 3 million people who had received a booster dose three to four weeks earlier. Such a sample size should be sufficient to achieve a margin of error of about 2.5% at a 95% confidence interval. The survey excluded, in particular, people who had already recovered from covid.
Among other things, the Israeli survey shows that:
1. Two-thirds of the respondents (66%) reported at least one side effect within three to four weeks after the booster.
2. Close to one-third of respondents (29%) reported that they had “difficulty performing daily activities” due to the booster side effects (women: 51%).
3. Close to one in three hundred respondents (0.3%) reported actual hospitalization (i.e. not just medical care) as a result of the side effects.
4. Nearly 10% of women under the age of 54 reported disruptions to their menstrual cycle after the booster. Half of these women reported ongoing menstrual symptoms in a follow-up survey two to three months after the initial survey.
5. 5.5% of the respondents reported chest pain (women: 7%), and 4.2% reported enlarged lymph nodes (women: 6%).
6. Close to 5% reported neurological problems (women: 6.9%), including Bell’s palsy (0.5%), blurred vision (0.5%), memory issues (0.4%), hearing issues (0.4%), convulsions (0.2%), and loss of consciousness (0.2%).
7. Close to 4% reported allergic reactions (women: 5.3%), including a rash, itching, difficulty breathing, and swelling of the face or throat.
8. About 25% of people with pre-existing auto-immune disorders, depression or anxiety reported a worsening of their symptoms following the booster.
9. 5% to 10% of people with diabetes, hypertension, and lung & heart disease also reported a worsening of their condition.
10. Finally, 0.2% of respondents reported an outbreak of herpes simplex (women: 0.4%), and 0.2% of respondents reported an outbreak of herpes zoster (i.e. shingles; women: 0.3%).